title: Successful treatment with dasatinib and allogeneic peripheral blood stem cell transplant for imatinib-resistant Philadelphia chromosome-positive acute lymphoblastic leukemia relapsing after bone marrow transplant and donor lymphocyte infusion.
authors: Takayoshi
authors: T
authors: Tachibana
authors: Ayumi
authors: A
authors: Numata
authors: Masatsugu
authors: M
authors: Tanaka
authors: Kenji
authors: K
authors: Motohashi
authors: Shin
authors: S
authors: Fujisawa
authors: Hiroyuki
authors: H
authors: Fujita
authors: Rika
authors: R
authors: Sakai
authors: Naoto
authors: N
authors: Tomita
authors: Atsuo
authors: A
authors: Maruta
authors: Yoshiaki
authors: Y
authors: Ishigatsubo
authors: Heiwa
authors: H
authors: Kanamori
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001549:Benzamides; D016026:Bone Marrow Transplantation; D000069439:Dasatinib; D019008:Drug Resistance, Neoplasm / Q000187:drug effects; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D006801:Humans; D000068877:Imatinib Mesylate; D017710:Lymphocyte Transfusion; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects; D010879:Piperazines / Q000494:pharmacology / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics / Q000628:therapy*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000494:pharmacology / Q000627:therapeutic use*; D012008:Recurrence; D013844:Thiazoles / Q000627:therapeutic use*; D014184:Transplantation, Homologous; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D013844:Thiazoles; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases; D016044:Fusion Proteins, bcr-abl; D000069439:Dasatinib